HIV-1 envelope determinants for cell tropism and chemokine receptor use

References

• Alkhatib, G., Combadiere, C., Broder, C. C., Feng, Y., Kennedy, P. E., Murphy, P. M. and Berger, E. A., 1996, CC CKR5: A RANTES, MIP-1a, MIP-1b receptor as a fusion cofactor for macrophage-tropic HIV-1. Science, 272, 1955-1958.
   Google Scholar
• Andeweg, A., Leeflang, P., Osterhaus, A. and Bosch, M., 1993, Both the V2 and V3 regions of the human immunodeficiency virus type 1 surface glycoprotein functionally interact with other envelope regions in syncytium formation. Journal of Virology, 67, 3232-3239.
   Google Scholar
• Berson, J. F. and Doms, R. W., 1997, Structure-function studies of the HIV-1 coreceptors. Seminars in Immunology, 10, 237-248.
   Google Scholar
• Boyd, M., Simpson, G., Cann, A., Johnson, M. and Weiss, R., 1993, A single amino acid substitution in the V1 loop of human immunodeficiency virus type 1 gp120 alters cellular tropism. Journal of Virology, 67, 3649-3652.
   Google Scholar
• Cao, J., Sullivan, N., Desjardin, E., Parolin, C., Robinson, J., Wyatt, R. and Sodroski, J., 1997, Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoprotein. Journal of Virology, 71, 9808–9812.
   PubMed Web of Science ®Google Scholar
• Carrillo, A. and Ratner, L., 1996, Cooperative effects of the human immunodeficiency virus type 1 envelope variable loops V1 and V3 in mediating infectivity for T cells. Journal of Virology, 70, 1310–1316.
   PubMedGoogle Scholar
• Chan, D. C., Fass, D., Berger, J. M. and Kim, P. S., 1997, Core structure of gp41 from the HIV envelope glycoprotein. Cell, 89, 263–273.
   PubMed Web of Science ®Google Scholar
• Cheng-Mayer, C., Quiroga, M., Tung, J. W., Dina, D. and Levy, J. A., 1990, Viral determinants of human immunodeficiency virus type 1 T-cell or macrophage tropism, cytopathogenicity, and CD4 antigen. Journal of Virology, 64, 4390–4398.
   PubMedGoogle Scholar
• Chesebro, B., Nishio, J., Perryman, S., Cann, A., O’Brien, W., Chen, I. S. Y. and Wehrly, K., 1991, Identification of human immunode-ficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells, and macrophages. Journal of Virology, 65, 5782–5789.
   PubMed Web of Science ®Google Scholar
• Chesebro, B., Wehrly, K., Nishio, J. and Perryman, S., 1992, Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homo-geneity in comparison with T-cell tropic isolates: definition of critical amino acids involved in cell tropism. Journal of Virology, 66, 6547–6554.
   PubMed Web of Science ®Google Scholar
• Chesebro, B., Wehrly, K., Nishio, J. and Perryman, S., 1996, Mapping of independent V3 envelope determinants of human immunodeficiency virus type 1 macrophage tropism and syncy-tium formation in lymphocytes. Journal of Virology, 70, 9055–9059.
   PubMedGoogle Scholar
• Cho, M. W., Lee, M. K., Carney, M. C., Berson, J. F., Doms, R. W. and Martin, M. A., 1997, Identification of determinants on a dual-tropic human immunodeficiency virus type-1 envelope glycoprotein that confer usage of CXCR4. Journal of Virology, 72, 2509–2515.
   Google Scholar
• Choe, H., Farzan, M., Sun, Y., Sullivan, N., Rollins, B., Ponath, P. D., Wu, L., Mackay, C. R., LaRosa, G., Newman, W., Gerard, N., Gerard, C. and Sodroski, J., 1996, The b-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell, 85, 1135–1148.
   PubMed Web of Science ®Google Scholar
• Cocchi, F., DeVico, A. L., Garzino-Demo, A., Arya, S. K., Gallo, R. C. and Lusso, P., 1995, Identification of RANTES, MIP-1a, and MIP-1b as the major HIV suppressive factors produced by CD8+ T cells. Science, 270, 1811–1815.
   PubMed Web of Science ®Google Scholar
• Cocchi, F., DeVico, A. L., Garzino-Demo, A., Cara, A., Gallo, R. C. and Lusso, P. 1996, The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection. Nature Medicine, 2, 1244–1247.
   PubMed Web of Science ®Google Scholar
• Collman, R., Balliet, J. W., Gregory, S. A., Friedman, H., Kolson, D. L., Nathanson, N. and Srinivasan, A., 1992, An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. Journal of Virology, 66, 7517–7521.
   PubMed Web of Science ®Google Scholar
• Connor, R. I., Mohri, H., Cao, Y. and Ho, D. D., 1993, Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunode-ficiency virus type 1-infected individuals. Journal of Virology, 67, 1772–1777.
   PubMed Web of Science ®Google Scholar
• Davis, C. B., Dikic, I., Unutmaz, D., Hill, C. M., Arthos, J., Siani, M. A., Thompson, D. A., Schlessinger, J. and Littman, D. R., 1997, Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5. Journal of Experimental Medicine, 186, 1793–1798.
   PubMedGoogle Scholar
• Dean, M., Carrington, M., Winkler, C., Huttley, G. A., Smith, M. W., Allikmets, R., Goedert, J. J., Buchbinder, S. P., Vittinghoff, E., Gomperts, E., Donfield, S., Vlahov, D., Kaslow, R., Saah, A., Rinaldo, C., Detels, R. and O’Brien, S. J., 1996, Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science, 273, 1856-1862.
   PubMed Web of Science ®Google Scholar
• DeJong, J., DeRonde, A., Keulen, W., Tersmette, M. and Goudsmit, J., 1992a, Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitutions. Journal of Virology, 66, 6777–6780.
   PubMedGoogle Scholar
• DeJong, J.-J., Goudsmit, J., Keulen, W., Klaver, B., Krone, W., Tersmette, M. and deRonde, A., 1992b, Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium fromation and replication capacity. Journal of Virology, 66, 757–765.
   Google Scholar
• Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Marzio, P. D., Marmon, S., Sutton, R. E., Hill, C. M., Davis, C. B., Peiper, S. C., Schall, T. J., Littman, D. R. and Landau, N. R., 1996, Identification of a major co-receptor for primary isolates of HIV-1. Nature, 381, 661–666.
   PubMed Web of Science ®Google Scholar
• Doms, R. W. and Moore, J. P., 1997, HIV coreceptor use: a molecular window into viral tropism. Los Alamos Database Part III, 1-10.
   Google Scholar
• Donzella, G. A., Schols, D., Lin, S. W., Este, J. A., Nagashima, K. A., Maddon, P. J., Allaway, G. P., Sakmar, T. P., Henson, G., Clercq, E. D. and Moore, J. P., 1997, AMD3100, a small molecule that interacts with the CXCR4 co-receptor to prevent HIV-1 entry. Nature Medicine, 4, 72–77.
   Google Scholar
• Doranz, B. J., Grovit-Ferbasi, K., Sharron, M. P., Mao, S. H., Goetz, M. B., Daar, E. S., Doms, R. W. and O’Brien, W. A., 1997, A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor. Journal of Experimental Medicine, 186, 1395–1400.
   PubMed Web of Science ®Google Scholar
• Doranz, B. J., Rucker, J., Yi, Y., Smyth, R. J., Samson, M., Peiper, S. C., Parmentier, M., Collman, R. G. and Doms, R. W., 1996, A dual-tropic primary HIV-1 isolate that uses fusin and the b-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell, 85, 1149–1158.
   PubMed Web of Science ®Google Scholar
• Dragic, T., Litwin, V., Allaway, G. P., Martin, S. R., Huang, Y., Nagashima, K. A., Cayanan, C., Maddon, P. J., Koup, R. A., Moore, J. P. and Paxton, W. A., 1996, HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature, 381, 667–673.
   PubMed Web of Science ®Google Scholar
• Edinger, A. L., Amedee, A., Miller, K., Doranz, B. J., Endres, M., Sharron, M., Samson, M., Lu, Z.-H., Clements, J. E., Murphey-Corb, M., Peiper, S. C., Parmentier, M., Broder, C. C. and Doms, R. W., 1997, Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency viruses. Proceedings of the National Academy of Sciences, 94, 4005–4010.
   PubMed Web of Science ®Google Scholar
• Feng, Y., Broder, C. C., Kennedy, P. E. and Berger, E. A., 1996, HIV-1 entry cofactor: functional cDNA cloning of a seven-transmem-brane domain, G-protein coupled receptor. Science, 272, 872–877.
   PubMed Web of Science ®Google Scholar
• Fouchier, R. A. M., Groenink, M., Kootstra, N. A., Tersmette, M., Huisman, H. G., Miedema, F. and Schuitemaker, H., 1992, Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. Journal of Virology, 66, 3183–3187.
   PubMed Web of Science ®Google Scholar
• Fox, D. G., Balfe, P., Palmer, C. P., May, J. C., Arnold, C. and McKeating, J. A., 1997, Length polymorphism within the second variable region of the human immunodeficiency virus type 1 envelope glycoprotein affects accessibility of the receptor binding site. Journal of Virology, 71, 759–765.
   PubMedGoogle Scholar
• Fung, M. S. C., Sun, C. R. Y., Gordon, W. L., Liou, R.-S., Chang, T. W., Sun, W. N. C., Daar, E. S. and Ho, D. D., 1992, Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120. Journal of Virology, 66, 848–856.
   PubMedGoogle Scholar
• Gorny, M. K., Moore, J. P., Conley, A. J., Karwowska, S., Sodroski, J., Williams, C., Burda, S., Boots, L. J. and Zolla-Pazner, S., 1994, Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1. Journal of Virology, 68, 8312–8320.
   PubMed Web of Science ®Google Scholar
• Groenink, M., Fouchier, R. A. M., Broersen, S., Baker, C. H., Koot, M., Wout, A. B. Van’t, Huisman, H. G., Miedema, F., Tersmette, and Schuitemaker, H., 1993, Relation of phenotype evolution of HIV-1 to envelope V2 configuration. Science, 260, 1513–1516.
   PubMed Web of Science ®Google Scholar
• Harrowe, G. and Cheng-Mayer, C., 1995, Amino acid substitution in the V3 loop are responsible for adaptation to growth in transformed T-cell lines of a primary human immunodeficiency virus type 1. Virology, 210, 490–494.
   PubMedGoogle Scholar
• He, J., Chen, Y., Farzan, M., Choe, H., Ohagen, A., Gartner, S., Busciglio, J., Yang, X., Hofmann, W., Newman, W., Mackay, C. R., Sodroski, J. and Gabuzda, D., 1997, CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature, 385, 645–649.
   PubMed Web of Science ®Google Scholar
• Hernandez, L. D., Hoffman, L. R., Wolfsberg, T. G. and White, J. M., 1996, Virus-cell and cell-cell fusion. Annual Reviews in Develop- mental Cell Biology, 12, 627–661.
   PubMed Web of Science ®Google Scholar
• Hoffman, T. L. and Doms, R. W., 1998, Chemokines and coreceptors in HIV/SIV-host interactions. AIDS, 12 (Suppl A), S17-S26.
   Google Scholar
• Hoffman, T. L., Stephens, E., Narayan, O. and Doms, R. W., 1998, Human immunodeficiency virus type 1 envelope determinants of the CCR2b, CCR3, STRL33, and APJ coreceptors. Proceedings of the National Academy of Sciences 95, 11360–11365.
   PubMed Web of Science ®Google Scholar
• Huang, Z. B., Potash, M. J., Simm, M., Shahabuddin, M., Chao, W., Gendelman, H. E., Eden, E. and Volsky, D. J., 1993, Infection of macrophages with lymphotropic human immunodeficiency virus type 1 can be arrested after viral DNA synthesis. Journal of Virology, 67, 6893–6896.
   PubMedGoogle Scholar
• Hwang, S. S., Boyle, T. J., Lyerly, H. K. and Cullen, B. R., 1991, Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science, 253, 71–74.
   PubMed Web of Science ®Google Scholar
• Jones, P. L., Korte, T. and Blumenthal, R., 1998, Conformational changes in cell surface HIV-1 envelope glycoproteins are triggered by cooperation between cell surface CD4 and corecep-tors. Journal of Biological Chemistry, 273, 404–409.
   PubMed Web of Science ®Google Scholar
• Kim, F. M., Kolson, D. L., Balliet, J. W., Srinivasan, A. and Collman, R. G., 1995, V3-independent determinants of macrophage tropism in a primary human immunodeficiency virus type 1 isolate. Journal of Virology, 69, 1755–1761.
   PubMedGoogle Scholar
• Kim, S., Ikeuchi, K., Groopman, J. and Baltimore, D., 1990, Factors affecting cellular tropism of human immunodeficiency virus. Journal of Virology, 64, 5600–5604.
   PubMedGoogle Scholar
• Koito, A., Harrowe, G., Levy, J. A. and Cheng-Mayer, C., 1994, Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization. Journal of Virology, 68, 2253–2259.
   PubMedGoogle Scholar
• Koito, A., Stamatatos, L. and Cheng-Mayer, C., 1995, Small amino acid sequence changes within the V2 domain can affect the function of a T-cell line tropic human immunodeficiency virus type 1 envelope gp120. Virology, 206, 878–884.
   PubMedGoogle Scholar
• Kwong, P. D., Wyatt, R., Robinson, J., Sweet, R. W., Sodroski, J. and Hendrickson, W. A., 1998, Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature, 393, 648–659.
   PubMed Web of Science ®Google Scholar
• Lapham, C. K., Ouyang, J., Chandrasekhar, B., Nguyen, N. Y., Dimitrov, D. S. and Golding, H., 1996, Evidence for cell-surface association between Fusin and the CD4-gp120 complex in human cell lines. Science, 274, 602–605.
   PubMed Web of Science ®Google Scholar
• Leonard, C. K., Spellman, M. W., Riddle, L., Harris, R. J., Thomas, J. and Gregory, T. J., 1990, Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. Journal of Biological Chemistry, 265, 10373–10382.
   PubMed Web of Science ®Google Scholar
• Lifson, J. D., Feinberg, M. B., Reyes, G. R., Babins, L., Bonapour, B., Chakrabarti, S., Moss, B., Wong-Stahl, F., Steiner, D. C. and Engelman, E. G., 1986, Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein. Nature, 323, 725–728.
   PubMed Web of Science ®Google Scholar
• Liu, R., Paxton, W. A., Choe, S., Ceradini, D., Martin, S. R., Horuk, R., MacDonald, M. E., Stuhlmann, H., Koup, R. A. and Landau, N. R., 1996, Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell, 86, 367–377.
   PubMed Web of Science ®Google Scholar
• Lu, Z., Berson, J. F., Chen, Y., Turner, J. D., Zhang, T., Sharron, M., Jenks, M. H., Wang, Z., Kim, J., Rucker, J., Hoxie, J. A., Peiper, S. C. and Doms, R. W., 1997, Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains. Proceedings of the National Academy of Sciences, 94, 6426–6431.
   PubMed Web of Science ®Google Scholar
• Michael, N. L., Louie, L. G., Rohrbaugh, A. L., Schultz, K. A., Dayhoff, D. E., Wang, C. E. and Sheppard, H. W., 1997, The role of CCR5 D32 and CCR2b 64I polymorphisms in HIV-1 transmis- sion and disease progression. Nature Medicine, 3, 1160–1162.
   PubMed Web of Science ®Google Scholar
• Modrow, S., Hahn, B. H., Shaw, G. M., Gallow, R. C., Wong-Staal, F. and Wolf, H., 1987, Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions. Journal of Virology, 61, 570–578.
   PubMed Web of Science ®Google Scholar
• Murakami, T., Nakajima, T., Koyanagi, Y., Tachibana, K., Fujii, N., Tamamura, H., Yoshida, N., Waki, M., Matsumoto, A., Yoshie, O., Kishimoto, T., Yamamoto, N. and Nagasawa, T., 1997, A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection. Journal of Experimental Medicine, 186, 1389–1393.
   PubMed Web of Science ®Google Scholar
• O’Brien, W. A., Koyanagi, Y., Namazi, A., Zhao, J.-Q., Diagne, A., Idler, K., Zack, J. A. and Chen, I. S. Y., 1990, HIV-1 tropism for mononulcear phagocytes can be determined by regions of gp120 outside the CD4-binding domain. Nature, 348, 69–73.
   PubMed Web of Science ®Google Scholar
• Palmer, C., Balfe, P., Fox, D., May, J. C., Frederiksson, R., Fenyo, E.-M. and Mckeating, J. A., 1996, Functional characterization of the V1/V2 region of human immunodeficiency virus type I. Virology, 220, 436–449.
   PubMedGoogle Scholar
• Rana, S., Besson, G., Cook, D. G., Rucker, J., Smyth, R. J., Yi, Y., Turner, J. D., Guo, H.-H., Du, J.-G., Peiper, S. C., Lavi, E., Samson, M., Libert, F., Liesnard, C., Vassart, G., Doms, R. W., Parmentier, M. and Collman, R. G., 1997, Role of CCR5 in infection of primary macropages and lymphocytes by macro-phage-tropic strains of human immunodeficiency virus: resistance to patient-derived and prototype isolates resulting from the Dccr5 mutation. Journal of Virology, 71, 3219–3227.
   PubMed Web of Science ®Google Scholar
• Rizzuto, C. D., Wyatt, R., Hernandez-Ramos, N., Sun, Y., Kwong, P. D., Hendrickson, W. A. and Sodroski, J., 1998, A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science, 280, 1949-1953.
   PubMed Web of Science ®Google Scholar
• Roos, M. T. L., Lange, J. M. A., Goede, R. E. Y. d., Coutinho, R. A., Schellekens, P. T. A., Miedema, F. and Tersmette, M., 1992, Viral phenotype and immune response in primary human immunode-ficiency virus type 1 infection. Journal of Infectious Diseases, 165, 427–432.
   Google Scholar
• Ross, T. M. and Cullen, B. R., 1998, The abiliby of HIV type 1 to use CCR3 as a coreceptor is controlled by envelope V1/V2 sequences acting in conjunction with a CCR5 tropic V3 loop. Proceedings of the National Academy of Sciences, 95, 7682–7686.
   PubMed Web of Science ®Google Scholar
• Samson, M., Libert, F., Doranz, B. J., Rucker, J., Liesnard, C., Farber, C.-M., Saragosti, S., LapoumUroulie, C., Cogniaux, J., Forceille, C., Muyldermans, G., Verhofstede, C., Burtonboy, G., Georges, M., Imai, T., Rana, S., Yi, Y., Smyth, R. J., Collman, R. G., Doms, R. W., Vassart, G. and Parmentier, M., 1996, Resistance to HIV-1 infection of Caucasian individuals bearing mutant alleles of the CCR5 chemokine receptor gene. Nature, 382, 722–725.
   PubMed Web of Science ®Google Scholar
• Schmidtmayerova, H., Alfano, M., Nuovo, G. and Burkinsky, M., 1998, Human immunodeficiency virus type 1 T-lymphotropic strains enter macrophages via a CD4-and CXCR4-mediated pathway: replication is restricted at a postentry level. Journal of Virology, 72, 4633–4642.
   PubMed Web of Science ®Google Scholar
• Schols, D., Este, J. A., Cabrera, C. and Clercq, E. D., 1998, T-cell line tropic human immunodeficiency virus type 1 that is made resistant to stromal cell-derived factor 1 alpha contains mutations in the envelope gp120 but does not show a switch in coreceptor use. Journal of Virology, 72, 4032–4037.
   PubMed Web of Science ®Google Scholar
• Schuitemaker, H., Koot, M., Koostra, N. A., Dercksen, M. W., Goede, R. E. Y. d., Steenwijk, R. P. v., Lange, J. M. A., Schattenkerk, J. K. M. E., Miedema, F. and Tersmette, M., 1992, Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T-cell tropic populations. Journal of Virology, 66, 1354–1360.
   Google Scholar
• Shioda, T., Levy, J. A. and Cheng-Meyer, C., 1991, Macrophage and T-cell line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene. Nature, 349, 167–169.
   PubMed Web of Science ®Google Scholar
• Shioda, T., Levy, J. A. and Cheng-Meyer, C., 1992, Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficency virus type 1. Proceedings of the National Academy of Sciences, 89, 9434–9438.
   PubMed Web of Science ®Google Scholar
• Simmons, G., Clapham, P. R., Picard, L., Offord, R. E., Rosenkilde, M. M., Schwartz, T. W., Buser, R., Wells, T. N. C. and Proudfoot, W. E. I., 1997, Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science, 276, 276–279.
   PubMed Web of Science ®Google Scholar
• Simmons, G., Wilkinson, D., Reeves, J. D., Dittmar, M. T., Beddows, S., Weber, J., Carnegie, G., Gesselberger, U., Gray, P. W., Weiss, R. A. and Clapham, P. R., 1996, Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. Journal of Virology, 70, 8355–8360.
   PubMed Web of Science ®Google Scholar
• Smyth, R. J., Yi, Y., Singh, A. and Collman, R. G., 1998, Determinants of entry cofactor utilization and tropism in a dualtropic human immunodeficiency type 1 primary isolate. Journal of Virology, 72, 4478–4484.
   PubMed Web of Science ®Google Scholar
• Sodroski, J., Goh, W. C., Rosen, C., Campbell, K. and Haseltine, W. A., 1986, Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature, 322, 470–474.
   PubMed Web of Science ®Google Scholar
• Speck, R. F., Wehrly, K., Platt, E. J., Atchison, R. E., Charo, I. F., Kabat, D., Chesebro, B. and Goldsmith, M. A., 1997, Selective employment of chemokine receptors as human immunodefi-ciency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop. Journal of Virology, 71, 7136–7139.
   PubMed Web of Science ®Google Scholar
• Starcich, B. R., Hahn, B. H., Shaw, G. M., McNeely, P. D., Modrow, S., Wolf, H., Parks, E. S., Parks, W. P., Josephs, S. F., Gallo, R. C. and Wong-Stahl, F., 1986, Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/ LAV, the retrovirus of AIDS. Cell, 45, 637–648.
   PubMed Web of Science ®Google Scholar
• Sullivan, N., Sun, Y., Sattentau, Q., Thali, M., Wu, D., Denisova, G., Gershoni, J., Robinson, J., Moore, J. and Sodroski, J., 1998, CD4-induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: conse-quences for virus entry and neutralization. Journal of Virology, 72, 4694–4703.
   PubMed Web of Science ®Google Scholar
• Sullivan, N., Thali, M., Furman, C., Ho, D. D. and Sodroski, J., 1993, Effect of amino acid changes in the V1/V2 region of the human immunodeficiency virus type 1 gp120 glycoprotein on subunit association, syncytium formation, and recognition by a neutraliz-ing antibody. Journal of Virology, 67, 3674–3679.
   PubMedGoogle Scholar
• Takeuchi, Y., Akutsu, M., Murayama, K., Shimizu, N. and Hoshino, H., 1991, Host range mutant of human immunodeficiency virus type 1: modification of cell tropismby a single point mutation at the neutralization epitope in the env gene. Journal of Virology, 65, 1710–1718.
   PubMed Web of Science ®Google Scholar
• Tersmette, M., deGoede, R. E. Y., Ai, B. J. M., Winkel, I. N., Gruters, R. A., Cuypers, H. T., Huisman, H. G. and Miedema, F., 1988, Differential syncytium-inducing capacity of human immunodefi-ciency virus isolates: Frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency virus syn-drome (AIDS) and AIDS-related complex. Journal of Virology, 62, 2026–2032.
   Google Scholar
• Tersmette, M., Lange, J. M. A., Goed, R. E. Y. d., Wolf, F. d., Schattenkerk, J. K. M. E., Schellekens, P. T. A., Coutinho, R. A., Huisman, H. G., Goudsmit, J. and Meidema, F., 1989, Association between biological properties of human immunode-ficiency virus variants and risk for AIDS and AIDS mortality. Lancet, i, 983–985.
   Google Scholar
• Thali, M., Moore, J. P., Furman, C., Charles, M., Ho, D. D., Robinson, J. and Sodroski, J., 1993, Characterization of con-served human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. Journal of Virology, 67, 3978–3988.
   PubMedGoogle Scholar
• Toohey, K., Wehrly, K., Nishio, J., Perryman, S. and Chesebro, B., 1995, Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affect-ing virus spread. Virology, 213, 70–79.
   PubMed Web of Science ®Google Scholar
• Trkola, A., Drajic, T., Arthos, J., Binley, J. M., Olson, W. C., Allaway, G. P., Cheng-Mayer, C., Robinson, J., Maddon, P. J. and Moore, J. P., 1996, CD4-dependent, antibody-sensitive interactions between HIV-1 and its coreceptor CCR-5. Nature, 384, 184–187.
   PubMed Web of Science ®Google Scholar
• Wang, W.-K., Dudek, T., Zhao, Y.-J., Brublay, H. G., Essex, M. and Lee, T.-H., 1998a, CCR5 coreceptor utilization involves a highly conserved arginine residue of HIV type 1 gp120. Proceedings of the National Academy of Sciences, 95, 5740–5745.
   PubMed Web of Science ®Google Scholar
• Wang, Z., Berson, J. F., Zhang, T., Cen, Y., Sun, Y., Sharron, M., Lu, Z. and Peiper, S. C., 1998b, CXCR4 sequences involved in coreceptor determination of human immunodeficiency virus type-1 tropism. Journal of Biochemistry, 273, 15007–15015.
   Google Scholar
• Weiss, C. D., Levy, J. A. and White, J. M., 1990, Oligomeric organization of gp120 on infectious human immunodeficiency virus type 1 particles. Journal of Virology, 64, 5674–5677.
   PubMedGoogle Scholar
• Weissenhorn, W., Dessen, A., Harrison, S. C., Skehel, J. J. and Wiley, D. C., 1997, Atomic structure of the ectodomain from HIV-1 gp41. Nature, 387, 426–430.
   PubMed Web of Science ®Google Scholar
• Weissman, D., Rabin, R. L., Arthos, J., Rubbert, A., Dybul, M., Swofford, R., Venkatesan, S., Farber, J. M. and Fauci, A. S., 1997, Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor. Nature, 389, 981–985.
   PubMedGoogle Scholar
• Westervelt, P., Trowbridge, D. B., Epstein, L. G., Blumberg, B. M., Li, X., Hahn, B. H., Shaw, G. M., Price, R. W. and Ratner, L., 1992, Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo. Journal of Virology, 66, 2577–2582.
   PubMedGoogle Scholar
• Willett, B. J., Picard, L., Hosie, M. J., Turner, J. D., Adema, K. and Clapham, P. R., 1997, Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses. Journal of Virology, 71, 6407–6415.
   PubMed Web of Science ®Google Scholar
• Wu, L., Gerard, N. P., Wyatt, R., Choe, H., Parolin, C., Ruffing, N., Borsetti, A., Cardoso, A. A., Desjardin, E., Newman, W., Gerard, C. and Sodroski, J., 1996, CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature, 384, 179–183.
   PubMed Web of Science ®Google Scholar
• Wyatt, R., Kwong, P. D., Desjardins, E., Sweet, R. W., Robinson, J., Hendrickson, W. A. and Sodroski, J. G., 1998, The antigenic structure of the HIV gp120 envelope glycoprotein. Nature, 393, 705–711.
   PubMed Web of Science ®Google Scholar
• Wyatt, R., Moore, J., Accola, M., Desjardin, E., Robinson, J. and Sodroski, J., 1995, Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding. Journal of Virology, 69, 5723–5733.
   PubMedGoogle Scholar
• Wyatt, R., Sullivan, N., Thali, M., Repke, H., Ho, D., Robinson, J., Posner, M. and Sodroski, J., 1993, Functional and immunologic characterization of human immunodeficiency virus type 1 envel-ope glycoproteins containing deletions of the major variable regions. Journal of Virology, 67, 4557–4565.
   PubMedGoogle Scholar
• Yi, Y., Rana, S., Turner, J. D., Gaddis, N. and Collman, R. G., 1998, CXCR4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of HIV-1. Journal of Virology, 72, 772–777.
   PubMed Web of Science ®Google Scholar
• Zhu, T., Mo, H., Wang, N., Nam, D. S., Cao, Y., Koup, R. A. and Ho, D. D., 1993, Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science, 261, 1179–1181.
   PubMed Web of Science ®Google Scholar